カテゴリ： MarketLine, イギリス, 企業調査

Allianz Insurance plc：企業の戦略・SWOT・財務情報

◆英語タイトル：Allianz Insurance plc - Strategy, SWOT and Corporate Finance Report
◆商品コード：DATA904C1158
◆発行会社（調査会社）：MarketLine
◆発行日：2018年7月
◆ページ数：35
◆レポート言語：英語
◆レポート形式：PDF
◆納品方法：Eメール
◆対象地域：イギリス
◆産業分野：サービス
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD175 ⇒換算￥25,900見積依頼/購入/質問フォーム
Site License（同一事業所内共有可）USD350 ⇒換算￥51,800見積依頼/購入/質問フォーム
Enterprisewide License（複数事業所内共有可）USD525 ⇒換算￥77,700見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※本体価格が￥30,000未満のレポートにつきましては、ハンドリングチャージ￥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※MarketLine社の概要はこちらでご確認いただけます。

このエントリーをはてなブックマークに追加
LINEで送る


【レポートの概要】

Allianz Insurance plc – Strategy, SWOT and Corporate Finance Report
Summary

Allianz Insurance plc – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Allianz Insurance plc (Allianz Insurance), a subsidiary of Allianz Holdings plc, is an insurance company which offers personal and business insurance product and services. The company’s personal insurance products include car insurance, home insurance, pet insurance, equine insurance, musical insurance, and legal protection insurance. Its business insurance products comprise office insurance, property owner insurance, contractor insurance, fleet insurance, flat owner insurance, retailer insurance, motor trade insurance, cargo insurance and commercial vehicle insurance. Allianz Insurance also provides engineering insurance, and claims and inspection services. The company markets its products through a network of brokers and agents located across the UK. It operates through its offices located in Guildford, Newcastle upon Tyne, Chelmsford, Glasgow, Lancaster, Leeds, Maidstone, Milton Keynes, Kingsway and Almondsbury, the UK. Allianz Insurance is headquartered in Guildford, the UK.

During FY2016, the company reported gross earned premium of GBP2,112.4 million, representing a decline of 1.2% in FY2016. Its net insurance revenue was GBP1,193.7 million in FY2016, a decline of 26% in FY2016.

Scope

- Detailed information on Allianz Insurance plc required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Allianz Insurance plc in the form of a SWOT analysis
- An in-depth view of the business model of Allianz Insurance plc including a breakdown and examination of key business segments
- Intelligence on Allianz Insurance plc’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Allianz Insurance plc, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Allianz Insurance plc and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Allianz Insurance plc as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Allianz Insurance plc’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Allianz Insurance plc: Company Overview 9
Allianz Insurance plc: Overview and Key Facts 9
Allianz Insurance plc: Overview 9
Allianz Insurance plc: Key Facts 9
Allianz Insurance plc: Key Employees 11
Allianz Insurance plc: Key Employee Biographies 13
Allianz Insurance plc: Major Products and Services 15
Allianz Insurance plc: Company History 16
Allianz Insurance plc: Management Statement 17
Allianz Insurance plc: Locations and Subsidiaries 18
Allianz Insurance plc: Key Competitors 20
Allianz Insurance plc: Company Analysis 21
Allianz Insurance plc: Business Description 21
Allianz Insurance plc: SWOT Analysis 22
Allianz Insurance plc: SWOT Overview 22
Allianz Insurance plc: Strengths 22
Allianz Insurance plc: Weaknesses 23
Allianz Insurance plc: Opportunities 23
Allianz Insurance plc: Threats 24
Allianz Insurance plc: Corporate Financial Deals Activity 25
Allianz Insurance plc: Financial Deals Overview 25
Allianz Insurance plc: Targets and Partners 26
Allianz Insurance plc: Top Deals 2014 – 2018YTD* 27
Allianz Insurance plc: Mergers and Acquisitions 28
Allianz Insurance plc: Partnership 29
Allianz Insurance plc: Recent Developments 30
Allianz Insurance plc: News and Events Summary 30
Allianz Insurance plc: Contracts 30
Allianz Insurance plc: Financial Deals 31
Allianz Insurance plc: IT Spending Announcements 31
Allianz Insurance plc: Regulatory and Legal Events 32
Allianz Insurance plc: Strategy and Operations 32
Appendix 33
Contact Us 33
Methodology 33
About MarketLine 34

List of Tables
Table 1: Allianz Insurance plc: Key Facts
Table 2: Allianz Insurance plc: Key Employees
Table 3: Allianz Insurance plc: Locations and Subsidiaries
Table 4: Allianz Insurance plc: Key Competitors
Table 5: Allianz Insurance plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 6: Allianz Insurance plc: Targets and Partners
Table 7: Allianz Insurance plc: Top Deals 2014 - 2018YTD*
Table 8: Allianz Insurance plc: M&A Volume and Value Trend (2014 - YTD*2018)
Table 9: Allianz Insurance plc: M&A Activity by Geography (2014 - YTD*2018)
Table 10: Allianz Insurance plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 11: Allianz Insurance plc: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 12: Allianz Insurance plc: News and Events Summary
Table 13: Allianz Insurance plc: Contracts
Table 14: Allianz Insurance plc: Financial Deals
Table 15: Allianz Insurance plc: IT Spending Announcements
Table 16: Allianz Insurance plc: Regulatory and Legal Events
Table 17: Allianz Insurance plc: Strategy and Operations

List of Figures
Figure 1: Allianz Insurance plc: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: Allianz Insurance plc: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: Allianz Insurance plc: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: Allianz Insurance plc: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: Allianz Insurance plc: Partnership Trend by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[Allianz Insurance plc：企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら
■おすすめ企業レポート■
  • Canada Goose Holdings Inc (GOOS)：企業の財務・戦略的SWOT分析
    Canada Goose Holdings Inc (GOOS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Bioqual Inc (BIOQ)：企業の財務・戦略的SWOT分析
    Summary Bioqual Inc (Bioqual) is a provider of contract research services which focuses on in vivo models of human diseases such as AIDS, influenza, RSV infection flavivirus infections including zika and dengue, malaria, hepatitis and cancer. The company evaluates vaccines, vaccine therapeutics, mic …
  • Enel Americas S.A. (ENELAM)：電力：M&Aディール及び事業提携情報
    Summary Enel Americas S.A. (Enel Americas), formerly Enersis Americas S.A., is an integrated electricity utility in Latin America. The group through its subsidiaries and affiliates carries out the generation, transmission and distribution of electricity in Argentina, Brazil, Colombia and Peru. Enel …
  • Sulzer Ltd (SUN)：企業の財務・戦略的SWOT分析
    Sulzer Ltd (SUN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Serodus ASA：製薬・医療：M&Aディール及び事業提携情報
    Summary Serodus ASA (Serodus) is a drug development company that develops treatments for unmet clinical needs in the areas of diabetes and diabetic comorbidities. The company’s pipeline products include SER150DN, an anti-inflammatory compound under development for diabetic nephropathy; SER130AMI, an …
  • CSL Limited：企業の戦略・SWOT・財務分析
    CSL Limited - Strategy, SWOT and Corporate Finance Report Summary CSL Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As
    Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report Summary Tek Art Insaat Ticaret Turizm Sanayi Ve Yatirimlar As - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's …
  • Lightbridge Corporation (LTBR)：電力：M&Aディール及び事業提携情報
    Summary Lightbridge Corporation (Lightbridge) is a nuclear fuel technology company, which develops thorium based nuclear fuel technologies for nuclear reactor systems, that increases the power output of commercial reactors; generates nuclear energy and the amount of nuclear waste on a per-megawatt-h …
  • SI2 Technologies, Inc.：企業の戦略・SWOT・財務情報
    SI2 Technologies, Inc. - Strategy, SWOT and Corporate Finance Report Summary SI2 Technologies, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Infant Bacterial Therapeutics AB (IBT B)-製薬・医療分野：企業M&A・提携分析
    Summary Infant Bacterial Therapeutics AB (IBT), a subsidiary of BioGaia AB is a pharmaceutical company that develops prophylactic therapies for the medical needs of the premature infant. The company develops pharmaceutical drug candidates for gastrointestinal neonatal condition that causes mucosal i …
  • LumiraDx Ltd (LMDX)：企業の財務・戦略的SWOT分析
    LumiraDx Ltd (LMDX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Renaissance Offshore LLC：石油・ガス：M&Aディール及び事業提携情報
    Summary Renaissance Offshore LLC (Renaissance Offshore) is an oil and gas exploration and development company. The company carries out the business of identification and acquisition of under-developed oil and gas assets in the Gulf of Mexico. It builds and manages a portfolio of assets on oil produc …
  • Noble Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Noble Energy Inc Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Noble Energy Inc (Noble) is an independent energy company that explores for and produces crude oil, natural gas and natural gas liquids (NGLs). The company’s portfolio includes both US unconventiona …
  • Guardian Industries Corp：企業の戦略的SWOT分析
    Guardian Industries Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • iTeos Therapeutics SA：製薬・医療：M&Aディール及び事業提携情報
    Summary iTeos Therapeutics SA (iTeos) is a biotechnology company that develops novel cancer immunotherapies. The company’s pipeline products include small molecule immunomodulators targeting IDO1, A2A, immune check points, STING agonist, and antibodies directed to TIGIT and Galectin 3. It also devel …
  • Genisphere LLC：製薬・医療：M&Aディール及び事業提携情報
    Summary Genisphere LLC (Genisphere) is a nanotechnology company that provides DNA-based targeted drug delivery solutions. The company utilizes its proprietary 3DNA platform which enables the application in gene delivery, biologics, small molecules, and RNAi therapeutics. It develops pipeline product …
  • Meera Industries Ltd (540519)：企業の財務・戦略的SWOT分析
    Meera Industries Ltd (540519) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Synedgen Inc-製薬・医療分野：企業M&A・提携分析
    Summary Synedgen Inc (Synedgen) is a biotechnology company that focuses on the discovery and development of polysaccharide-based drugs. The company’s pipeline products include SYGN 113; SYGN 115; SYGN 146; SYGN 303; SYGN 313 and SYGN 399 among others. Synedgen develops products for the treatment of …
  • Ginkgo BioWorks Inc：製薬・医療：M&Aディール及び事業提携情報
    Summary Ginkgo BioWorks Inc (Ginkgo BioWorks) is a biotechnology company which offers automated organism engineering, enzyme discovery and cultured fragrances. The company build's foundries to scale the process of organism engineering using software and hardware automation tools. It produces ingredi …
  • Velesto Energy Bhd (UMWOG)：石油・ガス：M&Aディール及び事業提携情報
    Summary Velesto Energy Bhd (Velesto) formerly UMW Oil & Gas Corp Bhd, a subsidiary of UMW Holdings Bhd, is an oil and gas company that offers drilling and oilfield services. The company’s services include offshore drilling, hydraulic workover services, threading, inspection and repair services. Its …

◆H&Iグローバルリサーチ株式会社のお客様（例）◆